Advanced
  Home Compare Reports

Comparison with Similar Reports

3D Printing Medical Devices Market by Component (3D Printer, 3D Bioprinter, Material, Software, Service), Technology (EBM, DMLS, SLS, SLA, DLP, Polyje...

Publisher:        MarketsandMarkets

# of Pages:        498

Rating: 

1 User License $4,950

Publication Date:  May, 2021

Price:       $4,950 / User License




1 INTRODUCTION 36
1.1 OBJECTIVES OF THE STUDY 36
1.2 MARKET DEFINITION 36
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 YEARS CONSIDERED FOR THE STUDY 39
1.4 CURRENCY USED FOR THE STUDY 39
1.5 MAJOR MARKET STAKEHOLDERS 39
1.6 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
FIGURE 1 RESEARCH DESIGN 41
2.1.1 SECONDARY DATA 42
2.1.1.1 Secondary sources 43
2.1.2 PRIMARY DATA 43
FIGURE 2 BREAKDOWN OF PRIMARIES: 3D PRINTING MEDICAL DEVICES MARKET 44
FIGURE 3 PRIMARY SOURCES: 3D PRINTING MEDICAL DEVICES MARKET 44
2.2 MARKET ESTIMATION METHODOLOGY 45
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 46
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019 & 2020) 46
FIGURE 5 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2019 & 2020) 47
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 48
2.2.2 END USER-BASED MARKET ESTIMATION 48
2.2.3 GROWTH FORECAST 49
2.2.4 PRIMARY RESEARCH VALIDATION 49
2.3 DATA TRIANGULATION 50
FIGURE 7 DATA TRIANGULATION METHODOLOGY 50
2.4 RESEARCH ASSUMPTIONS 51
2.5 RESEARCH LIMITATIONS 52
3 EXECUTIVE SUMMARY 53
FIGURE 8 3D PRINTING MEDICAL DEVICES MARKET, BY COMPONENT,
2021 VS. 2026 (USD MILLION) 53
FIGURE 9 3D PRINTING MEDICAL DEVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 54
FIGURE 10 3D PRINTING MEDICAL DEVICES MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 55
FIGURE 11 3D PRINTING MEDICAL DEVICES MARKET: REGIONAL SNAPSHOT 56
4 PREMIUM INSIGHTS 57
4.1 3D PRINTING MEDICAL DEVICES MARKET OVERVIEW 57
FIGURE 12 HIGH INCIDENCE OF DENTAL AND ORTHOPEDIC DISEASES TO DRIVE MARKET GROWTH 57
4.2 ASIA PACIFIC 3D PRINTING MEDICAL DEVICES MARKET, BY COUNTRY AND COMPONENT 58
FIGURE 13 JAPAN IS THE LARGEST MARKET FOR 3D PRINTING MEDICAL DEVICES IN THE ASIA PACIFIC 58
4.3 3D PRINTING MEDICAL DEVICES MARKET SHARE, BY END USER 59
FIGURE 14 HOSPITALS & SURGICAL CENTERS FORM THE LARGEST END-USER SEGMENT IN THIS MARKET 59
4.4 GEOGRAPHICAL SNAPSHOT OF THE 3D PRINTING MEDICAL DEVICES MARKET 60
FIGURE 15 MARKET IN CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
FIGURE 16 3D PRINTING MEDICAL DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
5.2.1 DRIVERS 62
5.2.1.1 Increasing public-private funding for 3D printing activities 62
5.2.1.2 High incidence of orthopedic and dental diseases 62
5.2.1.3 Easy development of customized medical products using 3D printing 63
5.2.1.4 Growing applications of 3D printing in the healthcare industry 64
5.2.1.5 Availability of advanced 3D printing materials for dental and medical applications 65
5.2.1.6 Increasing demand for 3D-printed products in cosmetology and the pharmaceutical industry 65
FIGURE 17 TOTAL NUMBER OF CRANIOFACIAL & MAXILLOFACIAL PROCEDURES IN THE US, BY TYPE (2019) 66
FIGURE 18 US: PATIENT SPENDING ON COSMETIC DENTISTRY SERVICES,
2015 VS. 2017 (USD MILLION) 67
5.2.2 RESTRAINTS 67
5.2.2.1 Shortage of a skilled workforce due to limited specialized training in additive manufacturing 67
5.2.2.2 Stringent regulatory process for the approval of 3D-printed medical devices 68
5.2.3 OPPORTUNITIES 68
5.2.3.1 Direct digital manufacturing 68
FIGURE 19 WORKFLOW COMPARISON: TRADITIONAL VS. DIGITAL DENTISTRY 70
5.2.3.2 Increasing adoption of CAD/CAM technology and desktop printers 70
TABLE 1 MAJOR INTRAORAL SCANNERS INTEGRATED WITH CAD/CAM LAUNCHED
IN RECENT YEARS 71
5.2.3.3 Consolidation of dental laboratories and hospitals 71
5.2.3.4 Growing demand for organ transplants 72
5.2.3.5 Expiry of key patents in the 3D printing industry 72
TABLE 2 KEY PATENT EXPIRY DATES IN THE 3D PRINTING MARKET 72
5.2.4 CHALLENGES 73
5.2.4.1 High capital investment and operating costs 73
5.2.4.2 Rising number of large medical practices 73
FIGURE 20 US: PERCENTAGE OF DENTISTS IN SOLO PRACTICES (2000 TO 2017) 74
5.2.4.3 Socio-ethical concerns related to the use of 3D-printed products 74
5.3 PORTER’S FIVE FORCES ANALYSIS 75
TABLE 3 3D PRINTING MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 75
5.3.1 THREAT OF NEW ENTRANTS 75
5.3.2 THREAT OF SUBSTITUTES 76
5.3.3 BARGAINING POWER OF SUPPLIERS 76
5.3.4 BARGAINING POWER OF BUYERS 77
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 77
5.4 PATENT ANALYSIS 78
5.4.1 PATENT PUBLICATION TRENDS FOR MEDICAL 3D PRINTING 78
FIGURE 21 PATENT PUBLICATION TRENDS FOR MEDICAL 3D PRINTING, 2015–2021 78
5.4.2 TOP APPLICANTS (COMPANIES) FOR 3D PRINTING TECHNOLOGY PATENTS 79
FIGURE 22 TOP APPLICANT COMPANIES FOR 3D PRINTING TECHNOLOGY PATENTS, 2015–2021 79
5.4.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR 3D PRINTING MEDICAL DEVICES PATENTS 80
FIGURE 23 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR 3D PRINTING MEDICAL DEVICES PATENTS, 2015–2021 80
5.4.4 PATENT PUBLICATION TRENDS FOR DENTAL 3D PRINTING 81
FIGURE 24 PATENT PUBLICATION TRENDS FOR DENTAL 3D PRINTING, 2015–2020 81
5.4.5 TOP APPLICANTS (COMPANIES) FOR DENTAL 3D PRINTING PATENTS 81
FIGURE 25 TOP APPLICANT COMPANIES FOR DENTAL 3D PRINTING PATENTS, 2015–2020 81
5.4.6 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR DENTAL 3D PRINTING PATENTS 82
FIGURE 26 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DENTAL 3D PRINTING PATENTS, 2015–2020 82
5.5 VALUE CHAIN ANALYSIS 82
FIGURE 27 3D PRINTING MEDICAL DEVICES MARKET: VALUE CHAIN ANALYSIS (2020) 83
5.6 ECOSYSTEM MAP 83
FIGURE 28 3D PRINTING MEDICAL DEVICES MARKET: ECOSYSTEM MAP (2020) 83
5.7 PRICING ANALYSIS 84
TABLE 4 PRICING ANALYSIS: 3D PRINTERS, 2020 (ASP IN USD) 84
5.8 COVID-19 IMPACT ON THE 3D PRINTING MEDICAL DEVICES MARKET 85
5.9 EVOLUTION OF 3D PRINTING TECHNOLOGY IN THE DENTAL AND MEDICAL SECTOR 86
FIGURE 29 DENTAL 3D PRINTING TECHNOLOGY EVOLUTION 86
FIGURE 30 EVOLUTION OF 3D PRINTING TECHNOLOGY FOR THE MEDICAL SECTOR 87
 
5.10 REGULATORY LANDSCAPE 88
5.10.1 US 88
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 89
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90
5.10.2 CANADA 90
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90
FIGURE 31 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 91
5.10.3 EUROPE 91
FIGURE 32 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 93
5.10.4 ASIA PACIFIC 94
5.10.4.1 JAPAN 94
5.10.4.1.1 Revision of the Pharmaceutical Affairs Law (PAL) and implementation of the new PMD Act in japan 94
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 95
5.10.4.2 CHINA 96
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 96
5.10.4.3 INDIA 98
5.11 AUSTRALIA 98
5.11.1 TGA DEVICE CLASSIFICATION 99
6 3D PRINTING MEDICAL DEVICES MARKET, BY APPLICATION 100
6.1 INTRODUCTION 101
TABLE 10 3D PRINTING MEDICAL DEVICES MARKET, BY APPLICATION,
2019–2023 (USD MILLION) 101
TABLE 11 3D PRINTING MEDICAL DEVICES MARKET, BY APPLICATION,
2024–2026 (USD MILLION) 101
6.2 CUSTOM PROSTHETICS & IMPLANTS 102
TABLE 12 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY TYPE,
2019–2023 (USD MILLION) 102
TABLE 13 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY TYPE,
2024–2026 (USD MILLION) 102
TABLE 14 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY REGION,
2019–2023 (USD MILLION) 103
TABLE 15 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY REGION,
2024–2026 (USD MILLION) 103
TABLE 16 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY TECHNOLOGY,
2019–2023 (USD MILLION) 104
TABLE 17 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY TECHNOLOGY,
2024–2026 (USD MILLION) 104
TABLE 18 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY COMPONENT,
2019–2023 (USD MILLION) 105
TABLE 19 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY COMPONENT,
2024–2026 (USD MILLION) 105
TABLE 20 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY END USER,
2019–2023 (USD MILLION) 106
TABLE 21 CUSTOM PROSTHETICS & IMPLANTS MARKET, BY END USER,
2024–2026 (USD MILLION) 106
6.2.1 CUSTOM CRANIOMAXILLOFACIAL IMPLANTS 107
6.2.1.1 Rising prevalence of head and neck cancer to increase the adoption of 3D-printed CMF implants 107
TABLE 22 CUSTOM CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION,
2019–2023 (USD MILLION) 107
TABLE 23 CUSTOM CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION,
2024–2026 (USD MILLION) 108
6.2.2 CUSTOM DENTAL PROSTHETICS & IMPLANTS 108
6.2.2.1 Growing edentulous population to encourage 3D printing of customized prosthodontics 108
TABLE 24 CUSTOM DENTAL PROSTHETICS & IMPLANTS MARKET, BY REGION,
2019–2023 (USD MILLION) 109
TABLE 25 CUSTOM DENTAL PROSTHETICS & IMPLANTS MARKET, BY REGION,
2024–2026 (USD MILLION) 109
6.2.3 CUSTOM ORTHOPEDIC IMPLANTS 110
6.2.3.1 Growing demand for patient-specific 3D-printed orthopedic implants to drive the growth of this market segment 110
TABLE 26 CUSTOM ORTHOPEDIC IMPLANTS MARKET, BY REGION,
2019–2023 (USD MILLION) 110
TABLE 27 CUSTOM ORTHOPEDIC IMPLANTS MARKET, BY REGION,
2024–2026 (USD MILLION) 111
6.3 SURGICAL GUIDES 111
TABLE 28 SURGICAL GUIDES MARKET, BY TYPE, 2019–2023 (USD MILLION) 112
TABLE 29 SURGICAL GUIDES MARKET, BY TYPE, 2024–2026 (USD MILLION) 112
TABLE 30 SURGICAL GUIDES MARKET, BY REGION, 2019–2023 (USD MILLION) 113
TABLE 31 SURGICAL GUIDES MARKET, BY REGION, 2024–2026 (USD MILLION) 113
TABLE 32 SURGICAL GUIDES MARKET, BY TECHNOLOGY, 2019–2023 (USD MILLION) 114
TABLE 33 SURGICAL GUIDES MARKET, BY TECHNOLOGY, 2024–2026 (USD MILLION) 114
TABLE 34 SURGICAL GUIDES MARKET, BY COMPONENT, 2019–2023 (USD MILLION) 115
TABLE 35 SURGICAL GUIDES MARKET, BY COMPONENT, 2024–2026 (USD MILLION) 115
TABLE 36 SURGICAL GUIDES MARKET, BY END USER, 2019–2023 (USD MILLION) 115
TABLE 37 SURGICAL GUIDES MARKET, BY END USER, 2024–2026 (USD MILLION) 116
6.3.1 DENTAL GUIDES 116
6.3.1.1 Advantages offered by 3D-printed dental guides to drive their adoption 116
TABLE 38 DENTAL GUIDES MARKET, BY REGION, 2019–2023 (USD MILLION) 117
TABLE 39 DENTAL GUIDES MARKET, BY REGION, 2024–2026 (USD MILLION) 117
6.3.2 ORTHOPEDIC GUIDES 118
6.3.2.1 Exponential growth in customized orthopedic guides to drive the growth of this market segment 118
TABLE 40 ORTHOPEDIC GUIDES MARKET, BY REGION, 2019–2023 (USD MILLION) 118
TABLE 41 ORTHOPEDIC GUIDES MARKET, BY REGION, 2024–2026 (USD MILLION) 119
6.3.3 CRANIOMAXILLOFACIAL GUIDES 119
6.3.3.1 Strategic initiatives for the adoption of 3D-printed CMF medical devices to drive the growth of this market segment 119
TABLE 42 CRANIOMAXILLOFACIAL GUIDES MARKET, BY REGION,
2019–2023 (USD MILLION) 120
TABLE 43 CRANIOMAXILLOFACIAL GUIDES MARKET, BY REGION,
2024–2026 (USD MILLION) 121
6.3.4 SPINAL GUIDES 121
6.3.4.1 Adoption of spinal guides is increasing for pedicle screw placement 121
TABLE 44 SPINAL GUIDES MARKET, BY REGION, 2019–2023 (USD MILLION) 122
TABLE 45 SPINAL GUIDES MARKET, BY REGION, 2024–2026 (USD MILLION) 122
6.4 TISSUE-ENGINEERED PRODUCTS 123
TABLE 46 TISSUE-ENGINEERED PRODUCTS MARKET, BY TYPE,
2019–2023 (USD MILLION) 123
TABLE 47 TISSUE-ENGINEERED PRODUCTS MARKET, BY TYPE,
2024–2026 (USD MILLION) 123
TABLE 48 TISSUE-ENGINEERED PRODUCTS MARKET, BY REGION,
2019–2023 (USD MILLION) 124
TABLE 49 TISSUE-ENGINEERED PRODUCTS MARKET, BY REGION,
2024–2026 (USD MILLION) 124
TABLE 50 TISSUE-ENGINEERED PRODUCTS MARKET, BY TECHNOLOGY,
2019–2023 (USD MILLION) 125
TABLE 51 TISSUE-ENGINEERED PRODUCTS MARKET, BY TECHNOLOGY,
2024–2026 (USD MILLION) 125
TABLE 52 TISSUE-ENGINEERED PRODUCTS MARKET, BY COMPONENT,
2019–2023 (USD MILLION) 126
TABLE 53 TISSUE-ENGINEERED PRODUCTS MARKET, BY COMPONENT,
2024–2026 (USD MILLION) 126
TABLE 54 TISSUE-ENGINEERED PRODUCTS MARKET, BY END USER,
2019–2023 (USD MILLION) 126
TABLE 55 TISSUE-ENGINEERED PRODUCTS MARKET, BY END USER,
2024–2026 (USD MILLION) 127
6.4.1 BONE & CARTILAGE SCAFFOLDS 127
6.4.1.1 Increasing incidence of musculoskeletal conditions to drive the demand for bone and cartilage scaffolds 127
TABLE 56 BONE & CARTILAGE SCAFFOLDS MARKET, BY REGION,
2019–2023 (USD MILLION) 128
TABLE 57 BONE & CARTILAGE SCAFFOLDS MARKET, BY REGION,
2024–2026 (USD MILLION) 129
6.4.2 LIGAMENT & TENDON SCAFFOLDS 129
6.4.2.1 Advances in tendon and ligament tissue engineering to fuel market growth 129
TABLE 58 LIGAMENT & TENDON SCAFFOLDS MARKET, BY REGION,
2019–2023 (USD MILLION) 130
TABLE 59 LIGAMENT & TENDON SCAFFOLDS MARKET, BY REGION,
2024–2026 (USD MILLION) 130
6.5 SURGICAL INSTRUMENTS 131
TABLE 60 SURGICAL INSTRUMENTS MARKET, BY TYPE, 2019–2023 (USD MILLION) 131
TABLE 61 SURGICAL INSTRUMENTS MARKET, BY TYPE, 2024–2026 (USD MILLION) 132
TABLE 62 SURGICAL INSTRUMENTS MARKET, BY REGION, 2019–2023 (USD MILLION) 132
TABLE 63 SURGICAL INSTRUMENTS MARKET, BY REGION, 2024–2026 (USD MILLION) 132
TABLE 64 SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY,
2019–2023 (USD MILLION) 133
TABLE 65 SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY,
2024–2026 (USD MILLION) 133
TABLE 66 SURGICAL INSTRUMENTS MARKET, BY COMPONENT,
2019–2023 (USD MILLION) 134
TABLE 67 SURGICAL INSTRUMENTS MARKET, BY COMPONENT,
2024–2026 (USD MILLION) 134
TABLE 68 SURGICAL INSTRUMENTS MARKET, BY END USER,
2019–2023 (USD MILLION) 134
TABLE 69 SURGICAL INSTRUMENTS MARKET, BY END USER,
2024–2026 (USD MILLION) 135
6.5.1 SURGICAL FASTENERS 135
6.5.1.1 Application of surgical fasteners is increasing in minimally invasive surgeries 135
TABLE 70 SURGICAL FASTENERS MARKET, BY REGION, 2019–2023 (USD MILLION) 136
TABLE 71 SURGICAL FASTENERS MARKET, BY REGION, 2024–2026 (USD MILLION) 136
6.5.2 SCALPELS 136
6.5.2.1 Demand for advanced scalpels is increasing among end users 136
TABLE 72 SURGICAL SCALPELS MARKET, BY REGION, 2019–2023 (USD MILLION) 137
TABLE 73 SURGICAL SCALPELS MARKET, BY REGION, 2024–2026 (USD MILLION) 137
6.5.3 RETRACTORS 137
6.5.3.1 Low development and production costs to drive the demand for retractors 137
TABLE 74 RETRACTORS MARKET, BY REGION, 2019–2023 (USD MILLION) 138
TABLE 75 RETRACTORS MARKET, BY REGION, 2024–2026 (USD MILLION) 138
6.6 HEARING AIDS 139
6.6.1 DEVELOPMENT OF 3D-PRINTED ANTI-BACTERIAL HEARING AIDS TO DRIVE MARKET GROWTH 139
TABLE 76 HEARING AIDS MARKET, BY REGION, 2019–2023 (USD MILLION) 139
TABLE 77 HEARING AIDS MARKET, BY REGION, 2024–2026 (USD MILLION) 140
TABLE 78 HEARING AIDS MARKET, BY TECHNOLOGY, 2019–2023 (USD MILLION) 140
TABLE 79 HEARING AIDS MARKET, BY TECHNOLOGY, 2024–2026 (USD MILLION) 141
TABLE 80 HEARING AIDS MARKET, BY COMPONENT, 2019–2023 (USD MILLION) 141
TABLE 81 HEARING AIDS MARKET, BY COMPONENT, 2024–2026 (USD MILLION) 141
TABLE 82 HEARING AIDS MARKET, BY END USER, 2019–2023 (USD MILLION) 142
TABLE 83 HEARING AIDS MARKET, BY END USER, 2024–2026 (USD MILLION) 142
6.7 STANDARD PROSTHETICS & IMPLANTS 143
6.7.1 RISING NUMBER OF SPORTS AND ACCIDENT-RELATED INJURIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 143
FIGURE 33 INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES IN THE US (2017) 143
FIGURE 34 GERMANY REPORTED THE HIGHEST NUMBER OF ROAD ACCIDENTS GLOBALLY (2016) 144
TABLE 84 STANDARD PROSTHETICS & IMPLANTS MARKET, BY REGION,
2019–2023 (USD MILLION) 145
TABLE 85 STANDARD PROSTHETICS & IMPLANTS MARKET, BY REGION,
2024–2026 (USD MILLION) 145
TABLE 86 STANDARD PROSTHETICS & IMPLANTS MARKET, BY TECHNOLOGY,
2019–2023 (USD MILLION) 146
TABLE 87 STANDARD PROSTHETICS & IMPLANTS MARKET, BY TECHNOLOGY,
2024–2026 (USD MILLION) 146
TABLE 88 STANDARD PROSTHETICS & IMPLANTS MARKET, BY COMPONENT,
2019–2023 (USD MILLION) 147
TABLE 89 STANDARD PROSTHETICS & IMPLANTS MARKET, BY COMPONENT,
2024–2026 (USD MILLION) 147
TABLE 90 STANDARD PROSTHETICS & IMPLANTS MARKET, BY END USER,
2019–2023 (USD MILLION) 148
TABLE 91 STANDARD PROSTHETICS & IMPLANTS MARKET, BY END USER,
2024–2026 (USD MILLION) 148
6.8 WEARABLE MEDICAL DEVICES 149
6.8.1 GROWING DEMAND FOR REMOTE MONITORING IS LIKELY TO FUEL THE GROWTH OF THIS MARKET SEGMENT 149
TABLE 92 WEARABLE MEDICAL DEVICES MARKET, BY REGION,
2019–2023 (USD MILLION) 149
TABLE 93 WEARABLE MEDICAL DEVICES MARKET, BY REGION,
2024–2026 (USD MILLION) 149
TABLE 94 WEARABLE MEDICAL DEVICES MARKET, BY TECHNOLOGY,
2019–2023 (USD MILLION) 150
TABLE 95 WEARABLE MEDICAL DEVICES MARKET, BY TECHNOLOGY,
2024–2026 (USD MILLION) 150
TABLE 96 WEARABLE MEDICAL DEVICES MARKET, BY COMPONENT,
2019–2023 (USD MILLION) 151
TABLE 97 WEARABLE MEDICAL DEVICES MARKET, BY COMPONENT,
2024–2026 (USD MILLION) 151
TABLE 98 WEARABLE MEDICAL DEVICES MARKET, BY END USER,
2019–2023 (USD MILLION) 151
TABLE 99 WEARABLE MEDICAL DEVICES MARKET, BY END USER,
2024–2026 (USD MILLION) 152
6.9 OTHER APPLICATIONS 152
TABLE 100 OTHER APPLICATIONS MARKET, BY REGION, 2019–2023 (USD MILLION) 153
TABLE 101 OTHER APPLICATIONS MARKET, BY REGION, 2024–2026 (USD MILLION) 153
TABLE 102 OTHER APPLICATIONS MARKET, BY TECHNOLOGY,
2019–2023 (USD MILLION) 154
TABLE 103 OTHER APPLICATIONS MARKET, BY TECHNOLOGY,
2024–2026 (USD MILLION) 154
TABLE 104 OTHER APPLICATIONS MARKET, BY COMPONENT,
2019–2023 (USD MILLION) 155
TABLE 105 OTHER APPLICATIONS MARKET, BY COMPONENT,
2024–2026 (USD MILLION) 155
TABLE 106 OTHER APPLICATIONS MARKET, BY END USER, 2019–2023 (USD MILLION) 155
TABLE 107 OTHER APPLICATIONS MARKET, BY END USER, 2024–2026 (USD MILLION) 156
7 3D PRINTING MEDICAL DEVICES MARKET, BY COMPONENT 157
7.1 INTRODUCTION 158
TABLE 108 3D PRINTING MEDICAL DEVICES MARKET, BY COMPONENT,
2019–2023 (USD MILLION) 158
TABLE 109 3D PRINTING MEDICAL DEVICES MARKET, BY COMPONENT,
2024–2026 (USD MILLION) 158
7.2 SOFTWARE & SERVICES 159
7.2.1 WITH ADVANCEMENTS IN PRINTING TECHNOLOGY AND MATERIALS, THE DEMAND FOR 3D PRINTING SERVICES IS INCREASING 159
TABLE 110 3D PRINTING SOFTWARE & SERVICES MARKET, BY REGION,
2019–2023 (USD MILLION) 160
TABLE 111 3D PRINTING SOFTWARE & SERVICES MARKET, BY REGION,
2024–2026 (USD MILLION) 160
7.3 EQUIPMENT 161
TABLE 112 3D PRINTING EQUIPMENT MARKET, BY TYPE, 2019–2023 (USD MILLION) 161
TABLE 113 3D PRINTING EQUIPMENT MARKET, BY TYPE, 2024–2026 (USD MILLION) 161
TABLE 114 3D PRINTING EQUIPMENT MARKET, BY REGION, 2019–2023 (USD MILLION) 162
TABLE 115 3D PRINTING EQUIPMENT MARKET, BY REGION, 2024–2026 (USD MILLION) 162
7.3.1 3D PRINTERS 163
7.3.1.1 Workflow enhancements and benefits of digitization to drive the adoption of 3D printers 163
TABLE 116 3D PRINTERS MARKET, BY REGION, 2019–2023 (USD MILLION) 163
TABLE 117 3D PRINTERS MARKET, BY REGION, 2024–2026 (USD MILLION) 164
7.3.2 3D BIOPRINTERS 164
7.3.2.1 Increasing clinical applications of 3D bioprinters to drive the growth of this market segment 164
TABLE 118 3D BIOPRINTERS MARKET, BY REGION, 2019–2023 (USD MILLION) 165
TABLE 119 3D BIOPRINTERS MARKET, BY REGION, 2024–2026 (USD MILLION) 166
7.4 MATERIALS 166
TABLE 120 3D PRINTING MATERIALS MARKET, BY TYPE, 2019–2023 (USD MILLION) 167
TABLE 121 3D PRINTING MATERIALS MARKET, BY TYPE, 2024–2026 (USD MILLION) 167
TABLE 122 3D PRINTING MATERIALS MARKET, BY REGION, 2019–2023 (USD MILLION) 168
TABLE 123 3D PRINTING MATERIALS MARKET, BY REGION, 2024–2026 (USD MILLION) 168
7.4.1 PLASTICS 168
TABLE 124 3D PRINTING PLASTICS MARKET, BY TYPE, 2019–2023 (USD MILLION) 169
TABLE 125 3D PRINTING PLASTICS MARKET, BY TYPE, 2024–2026 (USD MILLION) 169
TABLE 126 3D PRINTING PLASTICS MARKET, BY REGION, 2019–2023 (USD MILLION) 169
TABLE 127 3D PRINTING PLASTICS MARKET, BY REGION, 2024–2026 (USD MILLION) 170
7.4.1.1 Photopolymers 170
7.4.1.1.1 Photopolymers have wide applications in anatomical modeling 170
TABLE 128 3D PRINTING PHOTOPOLYMERS MARKET, BY REGION,
2019–2023 (USD MILLION) 171
TABLE 129 3D PRINTING PHOTOPOLYMERS MARKET, BY REGION,
2024–2026 (USD MILLION) 171
7.4.1.2 Thermoplastics 172
7.4.1.2.1 Thermoplastics are gaining popularity as viable alternatives to metals 172
TABLE 130 3D PRINTING THERMOPLASTICS MARKET, BY REGION,
2019–2023 (USD MILLION) 172
TABLE 131 3D PRINTING THERMOPLASTICS MARKET, BY REGION,
2024–2026 (USD MILLION) 173
7.4.2 METALS AND METAL ALLOYS 173
7.4.2.1 Superior mechanical strength and surface finish offered by metals to drive their demand 173
TABLE 132 3D PRINTING METALS AND METAL ALLOYS MARKET, BY REGION,
2019–2023 (USD MILLION) 174
TABLE 133 3D PRINTING METALS AND METAL ALLOYS MARKET, BY REGION,
2024–2026 (USD MILLION) 174
7.4.3 BIOMATERIALS 175
7.4.3.1 Increasing R&D activities for the use of biomaterials in 3D bioprinting to drive the growth of this segment 175
TABLE 134 3D PRINTING BIOMATERIALS MARKET, BY REGION,
2019–2023 (USD MILLION) 176
TABLE 135 3D PRINTING BIOMATERIALS MARKET, BY REGION,
2024–2026 (USD MILLION) 176
7.4.4 CERAMICS 176
7.4.4.1 Ceramics have wide applications in the dental industry 176
TABLE 136 3D PRINTING CERAMICS MARKET, BY REGION, 2019–2023 (USD MILLION) 177
TABLE 137 3D PRINTING CERAMICS MARKET, BY REGION, 2024–2026 (USD MILLION) 177
7.4.5 PAPER 178
7.4.5.1 Cost-effective paper-based 3D-printed anatomical models are used for training and education purposes 178
TABLE 138 3D PRINTING PAPER MARKET, BY REGION, 2019–2023 (USD MILLION) 178
TABLE 139 3D PRINTING PAPER MARKET, BY REGION, 2024–2026 (USD MILLION) 178
7.4.6 WAX 179
7.4.6.1 Increasing number of orthodontic procedures to drive the demand for wax material 179
TABLE 140 3D PRINTING WAX MARKET, BY REGION, 2019–2023 (USD MILLION) 179
TABLE 141 3D PRINTING WAX MARKET, BY REGION, 2024–2026 (USD MILLION) 179
7.4.7 OTHER MATERIALS 180
TABLE 142 LIQUID RESINS AVAILABLE IN THE DENTAL 3D PRINTING MARKET 180
TABLE 143 3D PRINTING MARKET FOR OTHER MATERIALS, BY REGION,
2019–2023 (USD MILLION) 181
TABLE 144 3D PRINTING MARKET FOR OTHER MATERIALS, BY REGION,
2024–2026 (USD MILLION) 181
 
8 3D PRINTING MEDICAL DEVICES MARKET, BY TECHNOLOGY 182
8.1 INTRODUCTION 183
TABLE 145 3D PRINTING MEDICAL DEVICES MARKET, BY TECHNOLOGY,
2019–2023 (USD MILLION) 183
TABLE 146 3D PRINTING MEDICAL DEVICES MARKET, BY TECHNOLOGY,
2024–2026 (USD MILLION) 184
8.2 LASER BEAM MELTING 184
TABLE 147 LASER BEAM MELTING TECHNOLOGIES MARKET, BY TYPE,
2019–2023 (USD MILLION) 185
TABLE 148 LASER BEAM MELTING TECHNOLOGIES MARKET, BY TYPE,
2024–2026 (USD MILLION) 185
TABLE 149 LASER BEAM MELTING TECHNOLOGIES MARKET, BY REGION,
2019–2023 (USD MILLION) 186
TABLE 150 LASER BEAM MELTING TECHNOLOGIES MARKET, BY REGION,
2024–2026 (USD MILLION) 186
8.2.1 DIRECT METAL LASER SINTERING 186
8.2.1.1 This technology enables the economical manufacturing of medical implants 186
TABLE 151 DIRECT METAL LASER SINTERING MARKET, BY REGION,
2019–2023 (USD MILLION) 187
TABLE 152 DIRECT METAL LASER SINTERING MARKET, BY REGION,
2024–2026 (USD MILLION) 188
8.2.2 SELECTIVE LASER SINTERING 188
8.2.2.1 High productivity of SLS to drive its adoption 188
TABLE 153 SELECTIVE LASER SINTERING MARKET, BY REGION,
2019–2023 (USD MILLION) 189
TABLE 154 SELECTIVE LASER SINTERING MARKET, BY REGION,
2024–2026 (USD MILLION) 189
8.2.3 SELECTIVE LASER MELTING 189
8.2.3.1 Technological advancements in SLM to drive its adoption 189
TABLE 155 SELECTIVE LASER MELTING MARKET, BY REGION,
2019–2023 (USD MILLION) 190
TABLE 156 SELECTIVE LASER MELTING MARKET, BY REGION,
2024–2026 (USD MILLION) 190
8.2.4 LASERCUSING 191
8.2.4.1 Emerging applications of LaserCUSING in designing medical instruments to drive the growth of this market segment 191
TABLE 157 LASERCUSING MARKET, BY REGION, 2019–2023 (USD MILLION) 191
TABLE 158 LASERCUSING MARKET, BY REGION, 2024–2026 (USD MILLION) 192
8.2.5 PHOTOPOLYMERIZATION 192
TABLE 159 PHOTOPOLYMERIZATION TECHNOLOGIES MARKET, BY TYPE,
2019–2023 (USD MILLION) 193
TABLE 160 PHOTOPOLYMERIZATION TECHNOLOGIES MARKET, BY TYPE,
2024–2026 (USD MILLION) 193
TABLE 161 PHOTOPOLYMERIZATION TECHNOLOGIES MARKET, BY REGION,
2019–2023 (USD MILLION) 194
TABLE 162 PHOTOPOLYMERIZATION TECHNOLOGIES MARKET, BY REGION,
2024–2026 (USD MILLION) 194
8.2.6 STEREOLITHOGRAPHY 195
8.2.6.1 Rapidity, ease of use, and accuracy to drive the adoption of stereolithography 195
TABLE 163 STEREOLITHOGRAPHY MARKET, BY REGION, 2019–2023 (USD MILLION) 196
TABLE 164 STEREOLITHOGRAPHY MARKET, BY REGION, 2024–2026 (USD MILLION) 196
8.2.7 DIGITAL LIGHT PROCESSING 196
8.2.7.1 The low output quality of DLP printing to hamper its adoption 196
TABLE 165 DIGITAL LIGHT PROCESSING MARKET, BY REGION,
2019–2023 (USD MILLION) 197
TABLE 166 DIGITAL LIGHT PROCESSING MARKET, BY REGION,
2024–2026 (USD MILLION) 198
8.2.8 POLYJET 3D PRINTING 198
8.2.8.1 High precision and wide application areas to drive the adoption of PolyJet 3D printing 198
TABLE 167 POLYJET 3D PRINTING TECHNOLOGY MARKET, BY REGION,
2019–2023 (USD MILLION) 199
TABLE 168 POLYJET 3D PRINTING TECHNOLOGY MARKET, BY REGION,
2024–2026 (USD MILLION) 199
8.2.9 TWO-PHOTON POLYMERIZATION 200
8.2.9.1 Advances in 2PP for biomedical applications to drive the growth of this market segment 200
TABLE 169 TWO-PHOTON POLYMERIZATION MARKET, BY REGION,
2019–2023 (USD MILLION) 200
TABLE 170 TWO-PHOTON POLYMERIZATION MARKET, BY REGION,
2024–2026 (USD MILLION) 201
8.3 DROPLET DEPOSITION/EXTRUSION-BASED TECHNOLOGIES 201
TABLE 171 DROPLET DEPOSITION/EXTRUSION-BASED TECHNOLOGIES MARKET,
BY TYPE, 2019–2023 (USD MILLION) 202
TABLE 172 DROPLET DEPOSITION/EXTRUSION-BASED TECHNOLOGIES MARKET,
BY TYPE, 2024–2026 (USD MILLION) 202
TABLE 173 DROPLET DEPOSITION/EXTRUSION-BASED TECHNOLOGIES MARKET,
BY REGION, 2019–2023 (USD MILLION) 203
TABLE 174 DROPLET DEPOSITION/EXTRUSION-BASED TECHNOLOGIES MARKET,
BY REGION, 2024–2026 (USD MILLION) 203
8.3.1 FUSED DEPOSITION MODELING 204
8.3.1.1 Low cost of FDM technology-based printers to drive their adoption 204
TABLE 175 FUSED DEPOSITION MODELING MARKET, BY REGION,
2019–2023 (USD MILLION) 204
TABLE 176 FUSED DEPOSITION MODELING MARKET, BY REGION,
2024–2026 (USD MILLION) 205
8.3.2 MICROEXTRUSION BIOPRINTING 205
8.3.2.1 Increasing research in the field of microextrusion to drive the growth of this market segment 205
TABLE 177 MICROEXTRUSION BIOPRINTING MARKET, BY REGION,
2019–2023 (USD MILLION) 206
TABLE 178 MICROEXTRUSION BIOPRINTING MARKET, BY REGION,
2024–2026 (USD MILLION) 206
8.3.3 MULTIPHASE JET SOLIDIFICATION 207
8.3.3.1 Lengthy production run as compared to other technologies to restrain the growth of this market segment 207
TABLE 179 MULTIPHASE JET SOLIDIFICATION MARKET, BY REGION,
2019–2023 (USD MILLION) 207
TABLE 180 MULTIPHASE JET SOLIDIFICATION MARKET, BY REGION,
2024–2026 (USD MILLION) 208
8.3.4 LOW-TEMPERATURE DEPOSITION MANUFACTURING 208
8.3.4.1 LDM is an emerging technology for tissue engineering 208
TABLE 181 LOW-TEMPERATURE DEPOSITION MANUFACTURING MARKET, BY REGION, 2019–2023 (USD MILLION) 209
TABLE 182 LOW-TEMPERATURE DEPOSITION MANUFACTURING MARKET, BY REGION, 2024–2026 (USD MILLION) 209
8.4 ELECTRON BEAM MELTING 210
8.4.1 PRINTERS BASED ON EBM TECHNOLOGY PRODUCE HIGH-DENSITY ORTHOPEDIC IMPLANTS AND HAVE RELATIVELY GOOD MECHANICAL PROPERTIES 210
TABLE 183 ELECTRON BEAM MELTING MARKET, BY REGION, 2019–2023 (USD MILLION) 211
TABLE 184 ELECTRON BEAM MELTING MARKET, BY REGION, 2024–2026 (USD MILLION) 211
8.5 THREE-DIMENSIONAL PRINTING/ADHESION BONDING/ BINDER JETTING 212
8.5.1 LOW COSTS HAVE DRIVEN THE DEMAND FOR INKJET TECHNOLOGY 212
TABLE 185 THREE-DIMENSIONAL PRINTING/ADHESION BONDING/BINDER JETTING MARKET, BY REGION, 2019–2023 (USD MILLION) 213
TABLE 186 THREE-DIMENSIONAL PRINTING/ADHESION BONDING/BINDER JETTING MARKET, BY REGION, 2024–2026 (USD MILLION) 213
8.6 OTHER TECHNOLOGIES 214
TABLE 187 OTHER TECHNOLOGIES MARKET, BY REGION, 2019–2023 (USD MILLION) 214
TABLE 188 OTHER TECHNOLOGIES MARKET, BY REGION, 2024–2026 (USD MILLION) 215
9 3D PRINTING MEDICAL DEVICES MARKET, BY END USER 216
9.1 INTRODUCTION 217
TABLE 189 3D PRINTING MEDICAL DEVICES MARKET, BY END USER,
2019–2023 (USD MILLION) 217
TABLE 190 3D PRINTING MEDICAL DEVICES MARKET, BY END USER,
2024–2026 (USD MILLION) 217
9.2 HOSPITALS & SURGICAL CENTERS 218
9.2.1 THE RAPID ADOPTION OF 3D PRINTING AS A SURGICAL PLANNING TOOL
BY HOSPITALS & SURGICAL CENTERS TO PROPEL THE GROWTH OF THIS SEGMENT 218
TABLE 191 3D PRINTING MEDICAL DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2019–2023 (USD MILLION) 219
TABLE 192 3D PRINTING MEDICAL DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2024–2026 (USD MILLION) 219
 
9.3 DENTAL & ORTHOPEDIC CLINICS 220
9.3.1 PREFERENCE FOR ORTHOPEDIC CLINICS IS GROWING OWING TO THEIR GREATER VERSATILITY 220
TABLE 193 3D PRINTING MEDICAL DEVICES MARKET FOR DENTAL & ORTHOPEDIC CLINICS, BY REGION, 2019–2023 (USD MILLION) 220
TABLE 194 3D PRINTING MEDICAL DEVICES MARKET FOR DENTAL & ORTHOPEDIC CLINICS, BY REGION, 2024–2026 (USD MILLION) 221
9.4 PHARMA-BIOTECH & MEDICAL DEVICE COMPANIES 221
9.4.1 GROWING APPLICATION OF 3D PRINTING IN PRECLINICAL TESTING TO BOOST SEGMENT GROWTH 221
TABLE 195 3D PRINTING MEDICAL DEVICES MARKET FOR PHARMA-BIOTECH &
MEDICAL DEVICE COMPANIES, BY REGION, 2019–2023 (USD MILLION) 222
TABLE 196 3D PRINTING MEDICAL DEVICES MARKET FOR PHARMA-BIOTECH &
MEDICAL DEVICE COMPANIES, BY REGION, 2024–2026 (USD MILLION) 222
9.5 ACADEMIC INSTITUTIONS & RESEARCH LABORATORIES 223
9.5.1 GROWING APPLICATION OF 3D PRINTING IN PRECLINICAL EDUCATION TO BOOST SEGMENT GROWTH 223
TABLE 197 TOP 10 NIDCR GRANTS TO US DENTAL INSTITUTIONS 224
TABLE 198 3D PRINTING MEDICAL DEVICES MARKET FOR ACADEMIC INSTITUTIONS & RESEARCH LABORATORIES, BY REGION, 2019–2023 (USD MILLION) 224
TABLE 199 3D PRINTING MEDICAL DEVICES MARKET FOR ACADEMIC INSTITUTIONS & RESEARCH LABORATORIES, BY REGION, 2024–2026 (USD MILLION) 225
9.6 CLINICAL RESEARCH ORGANIZATIONS 225
9.6.1 RISING OUTSOURCING OF RESEARCH FUNCTIONS BY MEDICAL OEMS TO BOOST SEGMENT GROWTH 225
TABLE 200 3D PRINTING MEDICAL DEVICES MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2019–2023 (USD MILLION) 226
TABLE 201 3D PRINTING MEDICAL DEVICES MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2024–2026 (USD MILLION) 226

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127